Alama Angela, Barbieri Federica, Spaziante Renato, Bruzzo Cristina, Dadati Patrizia, Dorcaratto Alessandra, Ravetti Jean Louis
Experimental Pharmacology, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132 Genova, Italy.
J Clin Neurosci. 2007 Apr;14(4):355-8. doi: 10.1016/j.jocn.2006.04.001. Epub 2007 Jan 19.
Forty-four evaluable patients with intracranial meningiomas were assessed for the expression of the cell-cycle regulator cyclin D1 and of proteins involved in proliferation and apoptosis such as PCNA, MIB-1, p53 and bcl-2. Analyses were carried out by western blot and immunohistochemistry after immediate processing of fresh tumor specimens. By western blot, expression of cyclin D1 significantly correlated with p53 (p=0.02) and with proliferative activity, as assessed by PCNA expression (p=0.0009). By immunohistochemistry, a significant relationship between cyclin D1 and the proliferation marker MIB-1 was confirmed (p=0.05), whereas significance with bcl-2 expression was not found (p=0.01). Moreover, although the association with tumor grade appeared of borderline statistical significance (p=0.07), all the grade II/III meningiomas showed increased expression of cyclin D1 and high proliferative activity. In conclusion, data from this preliminary study seem to suggest a potential value of the combined expression of cyclin D1 and proliferation indicators in defining subgroups of meningiomas with a more aggressive biological behavior.
对44例可评估的颅内脑膜瘤患者,评估细胞周期调节因子细胞周期蛋白D1以及参与增殖和凋亡的蛋白如增殖细胞核抗原(PCNA)、MIB-1、p53和bcl-2的表达。新鲜肿瘤标本经即时处理后,通过蛋白质印迹法和免疫组织化学法进行分析。通过蛋白质印迹法,细胞周期蛋白D1的表达与p53显著相关(p=0.02),并与通过PCNA表达评估的增殖活性相关(p=0.0009)。通过免疫组织化学法,证实细胞周期蛋白D1与增殖标志物MIB-1之间存在显著关系(p=0.05),而与bcl-2表达无显著关系(p=0.01)。此外,尽管与肿瘤分级的关联似乎具有临界统计学意义(p=0.07),但所有II/III级脑膜瘤均显示细胞周期蛋白D1表达增加且增殖活性高。总之,这项初步研究的数据似乎表明,细胞周期蛋白D1和增殖指标的联合表达在定义具有更具侵袭性生物学行为的脑膜瘤亚组方面具有潜在价值。